These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6430319)

  • 41. Calcium modulation and clinical effect. Profile of cyclandelate.
    Timmerman H
    Drugs; 1987; 33 Suppl 2():1-4. PubMed ID: 3622303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vasodilators in prevention and treatment of ischemic stroke.
    Taylor JR
    J Iowa Med Soc; 1970 Apr; 60(4):258-61. PubMed ID: 5434836
    [No Abstract]   [Full Text] [Related]  

  • 43. Modes and mechanisms of action of vasoactive drugs and especially of cyclandelate.
    Timmerman H
    Br J Clin Pract Suppl; 1984; 34():10-9. PubMed ID: 6430317
    [No Abstract]   [Full Text] [Related]  

  • 44. Letter: Cyclandelate and improved brain function.
    Wechsler AF
    Am J Psychiatry; 1974 Jun; 131(6):723. PubMed ID: 4827806
    [No Abstract]   [Full Text] [Related]  

  • 45. The melting-point of cyclospasmol and the quantitative determination of small amounts of 3.5.5.-trimethylcyclohexyl phenylglyoxylate in same.
    REKKER RF; ERNSTING MJ; NAUTA WT
    Pharm Weekbl; 1956 Jan; 91(1):1-6. PubMed ID: 13310216
    [No Abstract]   [Full Text] [Related]  

  • 46. The effects of cyclandelate on psychological test performance in patients with cerebral vascular insufficiency.
    Smith WL; Lowrey JB; Davis JA
    Curr Ther Res Clin Exp; 1968 Dec; 10(12):613-8. PubMed ID: 4972756
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of cyclandelate on mental function in patients with arteriosclerotic brain disease.
    Fine EW; Lewis D; Villa-Landa I; Blakemore CB
    Br J Psychiatry; 1970 Aug; 117(537):157-61. PubMed ID: 4921174
    [No Abstract]   [Full Text] [Related]  

  • 48. Vasodilators in geriatric psychiatry.
    Birkett DP
    J Med Soc N J; 1971 Aug; 68(8):619-23. PubMed ID: 4939868
    [No Abstract]   [Full Text] [Related]  

  • 49. Cerebral vasodilators.
    Judge TG
    Br Med J; 1971 Aug; 3(5772):480. PubMed ID: 4936031
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical efficacy and central mechanisms of cyclandelate in migraine: a double-blind placebo-controlled study.
    Siniatchkin M; Gerber WD; Vein A
    Funct Neurol; 1998; 13(1):47-56. PubMed ID: 9584874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A pilot study to evaluate the effect of acute and long-term administration of cyclandelate on the vigilance of subjects submitted to hypoxic conditions. Preliminary report.
    Schaffler K; Hörmann E; Arnold H
    Arzneimittelforschung; 1981; 31(6):1032-5. PubMed ID: 7196236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pharmacological treatment of vascular cognitive impairment].
    Bidzan L
    Przegl Lek; 2006; 63(3):131-3. PubMed ID: 16969897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of cyclandelate in chronic brain syndrome with arteriosclerosis.
    Fine EW
    Curr Ther Res Clin Exp; 1971 Sep; 13(9):568-74. PubMed ID: 5000458
    [No Abstract]   [Full Text] [Related]  

  • 54. Benefits of cyclandelate in the treatment of disorders of ageing.
    Le Poncin-Lafitte M
    Br J Clin Pract Suppl; 1984; 34():58-61. PubMed ID: 6430325
    [No Abstract]   [Full Text] [Related]  

  • 55. [Medical treatment of acute disorders of cerebral circulation].
    Buscaino GA
    Acta Neurol Quad (Napoli); 1980; 41():74-81. PubMed ID: 7293741
    [No Abstract]   [Full Text] [Related]  

  • 56. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study.
    Gerber WD; Schellenberg R; Thom M; Haufe C; Bölsche F; Wedekind W; Niederberger U; Soyka D
    Funct Neurol; 1995; 10(1):27-35. PubMed ID: 7649498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of cyclandelate (cyclospasmol) in treatment of circulatory disturbances.
    LESLIE RE
    Tex State J Med; 1960 May; 56():352-6. PubMed ID: 14415999
    [No Abstract]   [Full Text] [Related]  

  • 58. [Critical observations on vasodilator agents in peripheral vascular diseases and cerebrovascular disorders].
    Hamming JJ; van der Drift JH
    Ned Tijdschr Geneeskd; 1968 Mar; 112(13):611-4. PubMed ID: 5664995
    [No Abstract]   [Full Text] [Related]  

  • 59. Drugs for improvement of cerebral function in the elderly.
    Med Lett Drugs Ther; 1976 Apr; 18(9):38-9. PubMed ID: 1264019
    [No Abstract]   [Full Text] [Related]  

  • 60. [Report on the clinical trial with lamuran (II)].
    Steinorth G
    Med Welt; 1967 Sep; 36():2110-5. PubMed ID: 5614247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.